BUY Gland Pharma Limited — Nirav Chheda, Nirmal Bang Securities
byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·29 Sept · today
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Sept · 3w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Motilal Oswal12 Nov 2026 · ~1 year · target ₹3,690 · Active
- BUY — Sachin Janardan Sarvade, IDBI Capital Markets and Securities11 Nov 2026 · ~1 year · target ₹4,415 · Active
- BUY — Manas Jaiswal9 Nov 2026 · Same day · target ₹3,450 · Expired
- BUY — Nomura India Research9 Nov 2026 · ~1 year · target ₹3,790 · Active
- BUY — Bank of America9 Nov 2026 · ~1 year · target ₹3,800 · Active
More from Nirav Chheda, Nirmal Bang Securities
- BUY Emcure Pharmaceuticals12 Nov 2026 · ~1 year · target ₹2,751 · Active
- BUY DLF12 Nov 2026 · ~2 weeks · target ₹850 · Active
- BUY Prestige Estates Projects12 Nov 2026 · ~2 weeks · target ₹1,900 · Active
- BUY Nazara Technologies12 Nov 2026 · ~2 weeks · target ₹450 · Active
- BUY HDFC Life Insurance Company12 Nov 2026 · ~2 weeks · target ₹670 · Active

